Effect of time-restricted feeding on weight loss

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of time-restricted feeding (TRF) as a dietary strategy for weight loss over an 8-week period. Participants will be divided into two groups: one receiving caloric restriction without time limits on feeding, and the other receiving caloric restriction with time limits. The TRF group will have options for meal timing, either starting at 8 a.m. or 12 p.m. All participants will follow a caloric restriction of 513 to 770 kcal based on their estimated energy requirements.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Females;
* Aged between 18 and 59 years old;
* Body mass index equal or greater 25 kg/m²;
* Agree to sign the informed consent.

Exclusion Criteria:

* Any chronic health conditions (e.g. chronic renal failure, autoimmune, heart, and liver disease);
* Thyroid diseases or medications for its treatment;
* Medications known to affect total energy expenditure;
* Use of steroids, immunosuppressants or non-steroidal anti-inflammatory drugs, weight-loss medications, oral hypoglycemic agents or insulin and any medications that influence metabolic and/or inflammatory parameters;
* Previous surgery for weight loss;
* Pregnancy or breast-feeding;
* Smoking;
* Alcohol use (\>2 doses/day).

Where it's running

• Hospital da Clínicas
  Belo Horizonte, Minas Gerais, Brazil Recruiting
• Hospital das Clínicas
  Belo Horizonte, Minas Gerais, Brazil Recruiting

Study contacts

• Study coordinator: Adaliene VM Ferreira, PhD
• Email: adaliene@gmail.com
• Phone: +553134093680

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Nutrition support to improve dietary diversity in adults who are underweight or overweight/obese

  A community-based nutrition program will be tested in adults in Cambodia to see if it improves dietary diversity and if the program is acceptable and feasible to run.

  Recruiting National University of Singapore · Phnom Penh, Phnom Penh · NCT07836322

• Hesperidin for better thinking in overweight older adults

  In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.

  Recruiting University of Glasgow · Shanghai, Shanghai Municipality · NCT07750223

• MR-based performance tests for overweight and obesity

  This study tests mixed reality versions of mobility tests to see if they match conventional assessments in adults who are overweight or obese.

  Recruiting Selcuk University · Konya, Selcuklu · NCT07654439

• DA-302168S in adults with overweight or obesity

  A phase 3 trial in China is testing whether DA-302168S helps people who are overweight or obese lose weight compared with a placebo.

  Recruiting Phase 3 Chendu DIAO Pharmaceutical Group CO., LTD. · Beijing · NCT07629544

• Metabolic Health Trajectories in Overweight Chinese Adults

  This observational study follows overweight and obese Chinese adults to see how metabolic health changes over five years and whether people stay healthy, develop diabetes, or have complications.

  Recruiting Zhujiang Hospital · Guangzhou, Guangdong · NCT07584330

• Blood-count inflammation scores (SII and SIRI) to predict metabolic complications in adults with overweight or obesity

  This project will test whether two blood-count-based scores (SII and SIRI) can help predict metabolic complications and treatment response in adults with overweight or obesity.

  Recruiting University of Rijeka · Varaždin · NCT07431593

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.